Updated Quant Ratings for Small-Cap Consumer Staples Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 14 2026
0mins
Should l Buy HLF?
Source: seekingalpha
- Top Quant-Rated Companies: Herbalife (HLF) achieves a quant rating of 4.85, classified as a Strong Buy, indicating its strong valuation and profitability, which may attract investor interest and drive stock price increases.
- Strong Performers: Fresh Del Monte Produce (FDP) receives a quant rating of 4.70, also rated as a Strong Buy, suggesting its competitive edge and growth potential in the market, likely leading to increased capital inflow.
- Bottom Quant-Rated Companies: Oddity Tech (ODD) has a quant rating of 1.02, categorized as a Strong Sell, reflecting significant deficiencies in profitability and valuation, which may prompt investors to sell off its shares.
- Market Focus: As the earnings season concludes, investors are keenly interested in the quant ratings of small-cap consumer staples stocks, particularly those demonstrating strong performance in profitability and growth, which could influence overall market sentiment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HLF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HLF
Wall Street analysts forecast HLF stock price to rise
5 Analyst Rating
3 Buy
1 Hold
1 Sell
Moderate Buy
Current: 14.390
Low
8.00
Averages
14.60
High
20.00
Current: 14.390
Low
8.00
Averages
14.60
High
20.00
About HLF
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members. The Company has two geographical segments: Primary Reporting Segment (North America, Latin America, EMEA (Europe, Middle East, and Africa), and Asia Pacific regions) and China. Its products are classified into five categories. The Weight Management category includes meal replacements, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism-boosting teas. The Targeted Nutrition category features functional beverages and dietary supplements. The Energy, Sports, and Fitness category consists of products that support a healthy and active lifestyle. The Outer Nutrition segment offers facial skincare, body care, and hair care products. The Literature and Promotional Items include start-up kits, sales tools, and educational materials.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Revenue Expectations: Thorne is projected to reach $650 million in annual revenue for 2023, driven by the health-conscious focus of Gen Z and millennial consumers, indicating strong appeal in the younger market segment.
- Consumer Growth: The number of direct consumers has surged from 4 million at the end of 2023 to 7 million, fueling a 63% increase in direct sales, demonstrating the brand's expanding influence among younger shoppers.
- Market Trends: The U.S. vitamins and supplements market is expected to reach $125 billion by 2025, with an 11% growth projected by 2027, reflecting a shift towards proactive health management and demand for personalized products among younger consumers.
- Subscription Model: Thorne attracts consumers to subscribe by offering free shipping and a 10% discount on each refill, with about 50% of shoppers under 40 opting for subscriptions despite some hesitation, showcasing the brand's competitive edge in pricing and service.
See More
- Earnings Release Schedule: Herbalife will release its Q1 2026 financial results after NYSE trading closes on May 6, 2026, reflecting the company's ongoing commitment to transparency and investor communication.
- Management Conference Call: At 5:30 PM ET on the same day, Herbalife's senior management will host an audio webcast and conference call to discuss the financial results, enhancing engagement with investors.
- Webcast Access Link: Investors can join the webcast via the provided link, ensuring timely access to information and improving understanding of the company's performance.
- Company Background: Since 1980, Herbalife has focused on developing health and nutrition products, operating in over 90 markets, showcasing its extensive global reach and impact.
See More
- Acquisition Overview: Herbalife announced the acquisition of certain assets from Bioniq for $55 million, expected to close in Q2 2026, with an initial payment of $10 million and up to $95 million in contingent payments based on future performance over five years.
- Technological Integration Advantage: Bioniq's personalized supplement technology will be integrated with Herbalife's global distributor network and Pro2col's capabilities, enabling the company to offer a broader range of personalized nutritional supplements globally, enhancing market competitiveness and meeting growing consumer demand for personalization.
- Market Expansion Plans: Bioniq's personalized nutritional supplements are expected to be launched later this year through Herbalife's independent distributors in select European and U.S. markets, with plans to expand into additional markets, further strengthening Herbalife's influence in the global nutrition market.
- Enhanced Strategic Flexibility: The transaction includes a call option for Herbalife to acquire Bioniq LAB, allowing the company to evaluate potential opportunities in small molecules and peptides in a disciplined manner, thereby providing strategic support for long-term growth.
See More

Expansion of Personalized Nutrition: Herbalife is enhancing its capabilities in personalized nutritional supplements to better cater to individual health needs.
Strategic Acquisition: The company plans to achieve this expansion through the acquisition of BioNiq, a move aimed at strengthening its product offerings in the nutrition sector.
See More
- Acquisition Overview: Herbalife announced the acquisition of certain assets from UK-based Bioniq for $55 million, expected to close in Q2 2026, which will propel Herbalife's transformation into a technology-driven health platform and enhance its competitive edge in the market.
- Personalized Nutrition Expansion: Bioniq utilizes a patented product personalization engine, integrating individual health backgrounds and biomarker databases to offer personalized supplements for diverse consumers, which is anticipated to help Herbalife expand its personalized nutrition offerings globally.
- Strategic Partnership: As a long-time global nutrition partner of Herbalife, Cristiano Ronaldo supports this acquisition, emphasizing the importance of personalized nutrition in enhancing athletic performance, which is expected to further drive Herbalife's penetration in the sports nutrition market.
- Future Outlook: The acquisition includes not only Bioniq's product line but also grants Herbalife a call option to acquire Bioniq LAB, providing strategic flexibility to evaluate future opportunities in small molecules and peptides, thereby solidifying its leadership position in the personalized nutrition market.
See More
- Top Quant-Rated Companies: Herbalife (HLF) achieves a quant rating of 4.85, classified as a Strong Buy, indicating its strong valuation and profitability, which may attract investor interest and drive stock price increases.
- Strong Performers: Fresh Del Monte Produce (FDP) receives a quant rating of 4.70, also rated as a Strong Buy, suggesting its competitive edge and growth potential in the market, likely leading to increased capital inflow.
- Bottom Quant-Rated Companies: Oddity Tech (ODD) has a quant rating of 1.02, categorized as a Strong Sell, reflecting significant deficiencies in profitability and valuation, which may prompt investors to sell off its shares.
- Market Focus: As the earnings season concludes, investors are keenly interested in the quant ratings of small-cap consumer staples stocks, particularly those demonstrating strong performance in profitability and growth, which could influence overall market sentiment.
See More










